Manufacturing drugs on demand
The intricate, global supply chains and specialized production processes in modern industry, poses challenges - especially in pharmaceutical manufacturing, where supply chain disruptions can be life-threatening. Recent developments in continuous, on-demand drug manufacturing, like MIT’s compact synthesis unit, offer revolutionary solutions but clash with current regulatory frameworks, necessitating regulatory adaptation to embrace these technological advancements.